Default object view. Click to create a custom template, Node ID: 129107, Object ID: 75904

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

No relation

Yes

No relation

No

07/12/2015 5:16 pm

No